OA09504A - "Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". - Google Patents
"Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".Info
- Publication number
- OA09504A OA09504A OA60028A OA60028A OA09504A OA 09504 A OA09504 A OA 09504A OA 60028 A OA60028 A OA 60028A OA 60028 A OA60028 A OA 60028A OA 09504 A OA09504 A OA 09504A
- Authority
- OA
- OAPI
- Prior art keywords
- group
- hydrogen atom
- cirf
- lower alkyl
- case
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/60—Naphthoxazoles; Hydrogenated naphthoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909007813A FR2663633B1 (fr) | 1990-06-22 | 1990-06-22 | Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
OA09504A true OA09504A (fr) | 1992-11-15 |
Family
ID=9397889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60028A OA09504A (fr) | 1990-06-22 | 1991-06-21 | "Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". |
Country Status (16)
Country | Link |
---|---|
US (1) | US5179091A (de) |
EP (1) | EP0463945B1 (de) |
JP (1) | JPH0730054B2 (de) |
AT (1) | ATE132144T1 (de) |
AU (1) | AU631743B2 (de) |
CA (1) | CA2045256A1 (de) |
DE (1) | DE69115768T2 (de) |
DK (1) | DK0463945T3 (de) |
ES (1) | ES2084129T3 (de) |
FR (1) | FR2663633B1 (de) |
GR (1) | GR3019019T3 (de) |
IE (1) | IE912145A1 (de) |
NZ (1) | NZ238647A (de) |
OA (1) | OA09504A (de) |
PT (1) | PT98068A (de) |
ZA (1) | ZA914802B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930700494A (ko) * | 1990-04-10 | 1993-03-15 | 시게루 미즈노 | 신규한 옥사디논 유도체 |
US6140309A (en) * | 1996-03-12 | 2000-10-31 | University Of South Florida | Vasoactive effects and free radical generation by β-amyloid peptides |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
KR100371416B1 (ko) | 1998-03-16 | 2003-02-07 | 더 프록터 앤드 갬블 캄파니 | 피부 외형을 조절하는 조성물 |
CA2323364A1 (en) | 1998-03-16 | 1999-09-23 | The Procter & Gamble Company | Compositions for regulating skin appearance |
US8106094B2 (en) * | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8093293B2 (en) * | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US20020197244A1 (en) * | 1998-12-07 | 2002-12-26 | Miri Seiberg | Compositions and methods for regulating phagocytosis and ICAM-1 expression |
US7985404B1 (en) * | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
GB0004686D0 (en) * | 2000-02-28 | 2000-04-19 | Aventis Pharma Ltd | Chemical compounds |
US20040192669A1 (en) * | 2000-04-13 | 2004-09-30 | Rosenfeld Mark J. | Novel compounds for use in weight loss and appetite suppression in humans |
US7794761B2 (en) * | 2000-04-13 | 2010-09-14 | Seroctin Research & Technology, Inc. | Methods for inducing anti-anxiety and calming effects in animals and humans |
US8431550B2 (en) * | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7192615B2 (en) * | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
CN1596240A (zh) * | 2001-12-19 | 2005-03-16 | 阿特罗吉尼克斯公司 | 查耳酮衍生物及其治疗疾病的用途 |
US20030224075A1 (en) * | 2002-02-21 | 2003-12-04 | Jue-Chen Liu | Soy composition for balancing combination skin |
US20050004561A1 (en) * | 2003-07-01 | 2005-01-06 | Lynn Halas | Method for removing hair |
BRPI0415977A (pt) * | 2003-10-29 | 2007-01-23 | Johnson & Johnson Consumer Fr | composições compreendendo produtos de soja e ácidos dióicos |
US7524877B2 (en) | 2003-11-20 | 2009-04-28 | Seroctin Research & Technology, Inc. | Compounds for use in weight loss and appetite suppression in humans |
US20080008818A1 (en) * | 2006-06-23 | 2008-01-10 | Miri Seiberg | Partially denatured whole soybean extracts and methods of use thereof |
US20080089960A1 (en) * | 2006-10-16 | 2008-04-17 | Miri Seiberg | Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage |
CN103360338B (zh) * | 2013-07-30 | 2015-04-01 | 中国科学院新疆理化技术研究所 | 一种查尔酮苯并噻唑酰胺类衍生物的制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2244506B1 (de) * | 1973-06-26 | 1977-02-25 | Inst Nat Sante Rech Med | |
FR2244507A1 (en) * | 1973-06-26 | 1975-04-18 | Inst Nat Sante Rech Med | Chalcones and analogues - analgesics having low toxicity |
FR2588868B1 (fr) * | 1985-10-21 | 1988-11-10 | Negma Laboratoires | Acyl-7 benzoxazinones et leurs derives, procede pour les obtenir et compositions pharmaceutiques les contenant |
FR2646350B1 (fr) * | 1989-04-28 | 1991-06-28 | Adir | Nouveaux derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1990
- 1990-06-22 FR FR909007813A patent/FR2663633B1/fr not_active Expired - Fee Related
-
1991
- 1991-06-03 US US07/709,613 patent/US5179091A/en not_active Expired - Fee Related
- 1991-06-21 AT AT91401679T patent/ATE132144T1/de not_active IP Right Cessation
- 1991-06-21 AU AU79172/91A patent/AU631743B2/en not_active Ceased
- 1991-06-21 NZ NZ238647A patent/NZ238647A/xx unknown
- 1991-06-21 ES ES91401679T patent/ES2084129T3/es not_active Expired - Lifetime
- 1991-06-21 OA OA60028A patent/OA09504A/xx unknown
- 1991-06-21 PT PT98068A patent/PT98068A/pt not_active Application Discontinuation
- 1991-06-21 CA CA002045256A patent/CA2045256A1/fr not_active Abandoned
- 1991-06-21 ZA ZA914802A patent/ZA914802B/xx unknown
- 1991-06-21 EP EP91401679A patent/EP0463945B1/de not_active Expired - Lifetime
- 1991-06-21 DE DE69115768T patent/DE69115768T2/de not_active Expired - Fee Related
- 1991-06-21 DK DK91401679.5T patent/DK0463945T3/da active
- 1991-06-21 IE IE214591A patent/IE912145A1/en unknown
- 1991-06-24 JP JP3151498A patent/JPH0730054B2/ja not_active Expired - Fee Related
-
1996
- 1996-02-20 GR GR960400420T patent/GR3019019T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5179091A (en) | 1993-01-12 |
DK0463945T3 (da) | 1996-04-29 |
CA2045256A1 (fr) | 1991-12-23 |
JPH04230273A (ja) | 1992-08-19 |
AU631743B2 (en) | 1992-12-03 |
DE69115768T2 (de) | 1996-08-08 |
FR2663633A1 (fr) | 1991-12-27 |
IE912145A1 (en) | 1992-01-01 |
NZ238647A (en) | 1992-08-26 |
ES2084129T3 (es) | 1996-05-01 |
FR2663633B1 (fr) | 1994-06-17 |
EP0463945A1 (de) | 1992-01-02 |
EP0463945B1 (de) | 1995-12-27 |
PT98068A (pt) | 1992-03-31 |
GR3019019T3 (en) | 1996-05-31 |
AU7917291A (en) | 1992-01-02 |
ZA914802B (en) | 1992-04-29 |
ATE132144T1 (de) | 1996-01-15 |
DE69115768D1 (de) | 1996-02-08 |
JPH0730054B2 (ja) | 1995-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA09504A (fr) | "Nouvelles chalcones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
ATE114304T1 (de) | Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische präparate. | |
DK159148C (da) | Analogifremgangsmaade til fremstilling af tranexamsyrederivater | |
FI894061A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten , -disubstituoitujen N-sykloalkyylialkyylibentsyyliamiinien valmistamiseksi ja niiden synteesivälituotteita | |
NZ218243A (en) | B-carboline derivatives and pharmaceutical compositions | |
DE3850603D1 (de) | Arylaralkylether, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung. | |
OA09349A (fr) | "Nouveaux dérivés du 3-aminochromane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent". | |
SE8006953L (sv) | Heterocykliska foreningar | |
MX170732B (es) | Composicion de derivados de succinimida y su uso | |
SE8303913D0 (sv) | Heterocykliska foreningar | |
ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
IL97105A0 (en) | Indole derivatives,their preparation and pharmaceutical compositions containing them | |
ATE25523T1 (de) | Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel. | |
SE8100946L (sv) | Nya indanderivat, sett att framstella dem, anvendning derav som farmaceutika och farmaceutiska kompositioner som innehaller dess derivat | |
ATE19879T1 (de) | Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
OA08813A (fr) | Nouveaux dérivés de l'acide (dihydro-2,3, oxo-2 benzofurannyl-3)-2 acétique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent. | |
SE8405338A (sv) | (1,3)oxazino (4,3-a) isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
SE8802162L (sv) | Nya aminoacylater av glycerolacetal | |
SE8701524D0 (sv) | Nya sulfonamider och deras framstellningsforfarande | |
ATE132867T1 (de) | 20,21-dinoreburnaminderivate, substituiert in position 15, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende zusammensetzungen | |
GB2022583A (en) | New ionic polyiodo benzene derivatives useful as X-ray contrast media | |
ATE4384T1 (de) | Benzothiopyrano(2,3-c)pyridine und ihre saeureadditions-salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen. | |
EP0273357A3 (en) | Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments | |
SE8000138L (sv) | Nya 3-cyklopentan-1,2'(1'h)-naftalen-derivat, framstellning derav och lekemedel innehallande desamma |